Perrigo Will Acquire Orion Labs To Reach Australian Market
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's pending $49 million acquisition of Orion Laboratories marks the private labeler's entrance into the promising Australian OTC market and adds a "beachhead" for the firm's continued global expansion, analysts say
You may also be interested in...
Perrigo Sales Reach Record Highs Despite Manufacturing Restrictions
Acquisitions and new products helped Perrigo grow quarterly revenue 23% to $718 million, despite manufacturing restraints related to an FDA warning letter.
Perrigo Sales Reach Record Highs Despite Manufacturing Restrictions
Acquisitions and new products helped Perrigo grow quarterly revenue 23% to $718 million, despite manufacturing restraints related to an FDA warning letter.
Perrigo Sales Reach Record Highs Despite Manufacturing Restrictions
Acquisitions and new products helped Perrigo grow quarterly revenue 23% to $718 million, despite manufacturing restraints related to an FDA warning letter.